These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Malignant neuroleptic syndrome and Clostridium difficile: causal association or mere coincidence?]. Salas de Zayas R; Cerdeño Gómez C; Dolera Moreno C; Mármol E Med Intensiva; 2012; 36(1):63. PubMed ID: 22154227 [No Abstract] [Full Text] [Related]
6. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation. Mendhekar DN; Jiloha RC Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023 [No Abstract] [Full Text] [Related]
7. Suspected neuroleptic malignant syndrome in a patient receiving clozapine. Ganelin L; Lichtenberg PS; Marcus EL; Munter RG Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560 [TBL] [Abstract][Full Text] [Related]
8. Neuroleptic malignant syndrome with promethazine. Mendhekar DN; Andrade CR Aust N Z J Psychiatry; 2005 Apr; 39(4):310. PubMed ID: 15777370 [No Abstract] [Full Text] [Related]
9. Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome. Trutia A; Bledowski J; Pandurangi A; Kahn DA J Psychiatr Pract; 2008 Nov; 14(6):398-402. PubMed ID: 19057242 [No Abstract] [Full Text] [Related]
10. [Possible malignant neuroleptic syndrome associated with aripiprazole and imipramine and treated with bromocriptine]. Lopez E; Fraile S; Hidalgo FJ; García B Med Clin (Barc); 2013 Sep; 141(6):273-4. PubMed ID: 23578844 [No Abstract] [Full Text] [Related]
11. Successful treatment of neuroleptic malignant syndrome with bromocriptine. Janati A; Webb RT South Med J; 1986 Dec; 79(12):1567-71. PubMed ID: 3787295 [TBL] [Abstract][Full Text] [Related]
12. [Clinical aspects, pathogenesis and treatment of neuroleptic malignant syndrome]. Sep-Kowalikowa B Psychiatr Pol; 1989; 23(1):44-53. PubMed ID: 2573100 [No Abstract] [Full Text] [Related]
16. Exacerbating factors in neuroleptic malignant syndrome: comparisons between cases with death, sequelae, and full recovery. Nagamine M; Yoshino A; Sakurai Y; Sanga M; Takahashi R; Nomura S J Clin Psychopharmacol; 2005 Oct; 25(5):499-501. PubMed ID: 16160631 [No Abstract] [Full Text] [Related]
17. [The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam]. Real Rodríguez B; Ruibal JL; Grande Rodríguez S; Sueiro Pita B An Esp Pediatr; 1996 Jan; 44(1):60-2. PubMed ID: 8849063 [No Abstract] [Full Text] [Related]
18. [Malignant neuroleptic syndrome: successful treatment of a patient with bromocriptine]. Verhoeven WM; Elderson A Ned Tijdschr Geneeskd; 1985 Jan; 129(2):76-8. PubMed ID: 3969176 [No Abstract] [Full Text] [Related]
19. Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome. Atbasoglu EC; Ozguven HD; Can Saka M; Goker C J Clin Psychiatry; 2004 Dec; 65(12):1724-5. PubMed ID: 15641884 [No Abstract] [Full Text] [Related]
20. The neuroleptic malignant syndrome after open heart surgery: successful treatment with bromocriptine. Lieberman A; Pasternack P; Colvin S N Y State J Med; 1987 Jun; 87(6):362-3. PubMed ID: 3497368 [No Abstract] [Full Text] [Related] [Next] [New Search]